The inhibitory effect of an ergoline derivative (lergotrile, compound 83636) on prolactin secretion in man.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000328:Adult; D003864:Depression, Chemical; D004305:Dose-Response Relationship, Drug; D004873:Ergolines / Q000008:administration & dosage / Q000494:pharmacology*; D005640:Follicle Stimulating Hormone / Q000097:blood; D013006:Growth Hormone / Q000097:blood; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D010546:Perphenazine / Q000008:administration & dosage / Q000494:pharmacology; D011388:Prolactin / Q000097:blood / Q000378:metabolism*; D013974:Thyroxine / Q000097:blood; D013997:Time Factors; D014284:Triiodothyronine / Q000097:blood
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D004873:Ergolines; D014284:Triiodothyronine; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D013006:Growth Hormone; D010546:Perphenazine; D013974:Thyroxine; D006854:Hydrocortisone